Hi!

Just a few minutes ago at our Biopharma Comms Forum, T2B's AI Roundtable with Knowledge Partner Syneos Health Communications shared the findings of our inaugural AI in Biopharma Communications Survey.

The biggest takeaway: While many of us are regularly using AI in our work, there's a huge lag in the tools, training, governance, measurement, and expectations needed to support that use confidently, responsibly, and sustainably.

We invite you to peruse the full Survey Executive Summary. The report breaks down our findings of what we heard from the 117 respondents into five categories – stay tuned for a deeper dive on each one in the coming weeks. In the meantime...

Here’s a high-level view into what we found:

1. AI is already part of the work. Most respondents (95%) are using AI more than they were a year ago, and top use cases sit squarely inside core communications work.
2. Individuals are moving faster than organizations. Communicators are adopting tools and building habits faster than many organizations are standardizing workflows, governance, and access.
3. Access, governance, and trust are uneven. Many respondents have some guidance but fewer see it actively communicated and enforced, and fewer than half trust their organization or clients to use AI responsibly.
4. The appetite is there, but support is thin. Respondents want to do more with AI, but time, output trust, tool access, and task-specific training are holding them back.
5. The next phase is about professional evolution. AI is delivering efficiency today, but the bigger opportunity is helping communicators strengthen judgment, manage more complex workflows, and prove value.

Taken together, these findings suggest that AI adoption in biopharma comms has moved beyond experimentation and into daily practice. But folks have a LOT of questions about how to use AI most efficiently and responsibly.

How T2B is supporting the next phase:

The survey reinforced what we have been hearing across the T2B community; communicators want more practical, profession-specific support. They are experimenting, comparing notes, and learning by doing, but many still need more time, training, confidence in outputs, and clearer examples of how AI can support higher-value communications work.

That is where T2B will continue to focus: practical programming, peer exchange, and resources that help biopharma communicators use AI with more clarity and confidence.

Our next AI Roundtable event on July 28th will directly address one of the clearest needs identified in the survey: how to think about agentic AI and the shift from prompting to responsible delegation in strategic communications work.

Q3 AI Roundtable Event: How Agentic AI Is Moving Strategic Communicators from Prompting to Delegating

Tuesday, July 28th @ 12 p.m. ET / 9 a.m. PT / 5 p.m. BST

Join Monica Aguilar (T2B AI Roundtable member + Dragonfly AI) and Skye King (Geode Lifeworks) for this workshop-style session on what agentic AI means in practice, where communicators are beginning to experiment, and how these emerging capabilities may reshape strategic communications work in the years ahead.

Registration is now open here. Free and exclusive to T2B Pro and Student members.

Thank you, again, to T2B’s AI Roundtable and Knowledge Partner, Syneos Health Communications, for your work on this survey, as well as to everyone who submitted a response. We're looking forward to continuing to support this community in navigating the use of AI in our day-to-day.

Lynnea

​
​